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Summary: A procedure for the determination of senim high-density lipoprotein choline-containing phospholipids is
described. The choline-containing phospholipids represent 91—97% of the total serum and high-density lipoprotein
phospholipids, which have previously been determined in relation to liver disease, neoplastic disorders, diabetes
rnellitus and atherosclerosis. The eiizymatic ässay is quick, simple and precise. No interference was found from the
precipitating agents used to isolate the high-density lipoprotein fraction. Several serum samples were assayed for
high-density lipoprotein cholesterol and choline-containing phospholipids. From this preliminary data there would
appear to be a correlation between these two lipid classes.
Bestimmung der Cholin enthaltenden Phospholipide in High Density Lipoproteinen
Zusammenfassung: Ein Verfahren zur Bestimmung der Cholin enthaltenden Phospholipide in High Density Lipo-
proteinen des Serums wird beschrieben. Die Cholin enthaltenden Phospholipide machen 91—97% der gesamten
Phospholipide in Serum und High Density Lippprpteinen aus. Phospholipide wurden bereits früher in Zusammenhang
mit Lebererkrankuiigen, Neoplasien, Diabetes mellitus und Arteriosklerose bestimmt.
Die enzymatisehe Bestimmung ist schnell, einfach und zuverlässig. Fallungsreagenzieii zur Isolierung der High Density
Lipoprotein-Fräktion stören die Bestimmung nicht. Zahlreiche Serumproben wurden auf High Density Lipoprotein-
Cholesterin und Cholin enthaltende Phospholipide untersucht. Aufgrund dieser vorläufigen Ergebnisse scheint eine
Korrelation zwischen diesen beiden Lipidklassen zu bestehen.
Introduction
The determination öf total serum phospholipids has
previpusly been performed in thestudy pf .several
disease states, primaiüy for research purpöses. They are
usually detennined by chemicäl digestion of the organic
portipn pf the phospholipids followed by phpsphate
determination. Total serum phospholipids have beeil
measured in relation to extrahepatic obstruction (1),
certain neoplastic disorders (2), diabetes mellitus (3)
and atherosclerosis (3,4).
Supported in part by a Grant-in-Aid from the Michigan Heart
Association, Citation Qinical Laboratories, Ltd., Southfield,
MI and the Detroit Receiving Hospital Research Corporation.
The determination of serum high-density lipoprotein
(HDL) chplesterol has become a widely used test for
ässessülg the predispositioh to coronary heart disease
since HDL cholesterol levels have been shown to be
inversely related to the risk of developing coronary
heart disease (5). There may also be a relationship
between serum HDL-choline-containing phospholipids
and the risk of developing coronary heart disease, due
to the role of phospholipids in lipoproteins. Phospho-
lipids have been reported to stabilize lipoproteins and
may be necessary for the binding of cholesterol and its
esteirs to the lipoproteins (6, 7).
A method for the determination of total serum choline-
containing phospholipids has been previously described
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(8). This procedure utilized phospholipase D from
Streptomyces chromofuscus to hydrolyze choline from
phosphatidylcholine, lysophosphatidylcholine and
sphingomyelin. It is of note that not all phospholipids
contain choline. However, those that do comprise 91-
97% of the total phospholipids found in serum (9,10).
Choline oxidase was theri used to generate hydrogen
peroxide from the choline, and the hydrogen peroxide
was in turn utilized in the peroxidase catalyzed oxidative
coupling of 4-aminoantipyrine and phenol to form a -
red quinonimine chromogen. This procedure has since
been applied to the determination of HDL choline-con-
taining phospholipids (3, 11-13). Since the amount of
choline-containing phospholipids in the serum HDL
fraction is typically only 48% of the total serum choline-
containing phospholipids (9) the original proced re was
modified to increase its sensitivity by the Substitution of
sodium 2-hydroxy-3,5-dichlorobenzenesulfonate for
phenol in the peroxidase-catalyzed indicator reaction.
This type of modification has been used previously in
procedures for the determination of HDL cholesterol
(14) and choline-containing phospholipids in amniotic
fluid (15). The use of 2-hydroxy-3,5-dichlorobenzene-
sulfonate has been shown to produce a several-fold
increase in sensitivity over that of phenol (14) thus,
facilitating a marked improvement in the sensitivity and
precision of lipid determinations.
In the present report the characteristics of this proce-
dure are described including the possible interfering
effects of the precipitating reagents that were used
previously in an HDL cholesterol procedure (14). This
precipitating reagent has previously been compared with
several other precipitating agents for possible interfering
effects in an enzymatic HDL cholesterol assay (16).
Finally, this procedure for HDL choline-containing
phospholipids is used iri a preliminary investigation into
the possible correlation between serum HDL cholesterol
and HDL choline-containing phospholipids. To this end,
several serum samples, ranging widely in total cholesterol
concentrations, were assayed for both HDL cholesterol
and choline-containing phospholipids and the degree, of
correlation between them was determined.
Materials and Methods
Tris-hydrochloride was obtained from Research Plus Laboratories*
Inc. (Denville,N.J. 07834). Triton X-100, magnesium acetate,
4-aminoantipyrine, Ζ,-α-phosphatidylcholine (dipalmitoyl,
synthetic) and peroxidase (from h rseradish; hydrogen-peroxide
oxidoreductase, EC 1.11.1.7) were obtained from Sigma Chemi-
cal Co. (St. Louis, MO 63178). Calcium Chloride dihydrate was
obtained from Mallinckrodt Inc. (St. Louis, MO 63134). Choline
oxidase (from Arthrobacter globiformis\ choline: oxygen 1-oxido-
reductase; EC 1.1.3.17) and phospholipase D (from Strepto-
myces chromofuscus ι phosphatidylcholine phosphatidohydrolase;
EC 3.1.4.4) were obtained from Fermco Biochemies, Inc. (Elk
Grove Village, IL 60007). Sodium 2-hydroxy-3,5-dichlorobenzene-
sulfonate was obtained either from Research Organics, Inc.
(Cleveland, OH 44125) or Biosynth International (Skokie,
IL 60077) or was prepared s previously described (15, 17).
Sodium dextran sulfate 500 was obtained from Pharmacia Fine
Chemicals, Inc. (Piscataway, NJ 08854). Choline Chloride was
obtained from Eastman Organic Chemicals (Rochester,
NY 14650). The enzymatic cholesterol reagent without phenol
was generously supplied by Dr. Carol Cox of Abbott Laboratories
(Diagnostics Division, South Pasadena CA 91030). The chemical
composition of this reagent has been previously described (14).
Cholesterol Standards were also obtained frtfm Abbott Labora-
tories.
All spectrophotometric work was performed oh either a Beck-
man Model 25 Spectrophotpmeter (Beckman Instruments,
Fullerton, CA 92634), or a ilford Model 300N Spectcpphoto-
meter (Gilford Instrument Laboratories, Inc., Oberlin,
OH 44074).
Reagents
Stock phospholipid reagent: Prepare a Tris-HCl buffer, 50 minol/1,
pH 7.8, to contain 2 g/i Triton X-100, 2.9 mmol/l 4^ηιίηθΑηί^
pyrine and 500 μιηοΐ/ΐ CaCli · 2H?O. Stpred at 4 °C this reagent
is stable for at least one month.
Working phospholipid reagent: Prepare this reagent to contain
l kU/1 phpsphplipase D, l kU/1 choline oxidase and 10 kU/1
peroxidase in the above stock phospholipid reagent. Stored at
4 °C this re gent is stable for abput 3 days.
Sodium 2+hydroxy-3,5-dichlorobenzenesuifonate reagent: Prepare
a Tris-HCl buffer, 50 mni l/1, pH 7.8, tp contain 2 g/l Triton
X^IOO and 154 mmol/l sodium 2-hydbroxy-3,5-dichlorobenzene-
sulfonate. Stored at 4 °C this reagent is stable for at least l
month.
Lecithin Standards: Ζ,-α-phosphatidylcholine (dipalmitoyl, sym
thetic) was dissolved in deionized water, cpntainiiig 5 g/l Triton
X-100j to a concentration of 3.0 mmol/l. Serial dilutions qf this
Standard were made with 5 g/l Triton X-100 to contain 0.5,1.0,
1.5 and 2:0 irimpl/l lecithin.
Cholesterol reagent: Prepare this reagent by reconstitution of
the previPusly described dry ehzyme reagent (14) with deiPriized
water containing 4-aniinoantipyrine and Vhydroxy-3,5-dichloro-
benzeriesulfonate to final concentrations of 2.4 and 9 mmol/l,
respectively.
Magnesium acetate: Prepare this reagent to contain 2 mol/1
magnesium acetate in deionized water.
Dextran sulfate 500: Prepare this re gent to contain 20 g/l
dextran sulfate 500 in deionized water.
All enzyfne units quoted are used s defiried by the sappliers.
Procedures
Isolation of serum HDL fractions ·
To l ml of serum add 50 μΐ of dextran sulfate 500 solution arid
mix well. Subsequently 50 μΐ of magnesium acetate solutiPn was
added arid mixed well. This mixt re was theri allowed to stand
at room temperature for 10 min followed by centrifugation at
1200 g for 15 min. After centrifugation the HDL-containing
supernatant was transferred to a clean tube (18). Note that this
prPcedure may be scaled down considerably.
Determination of choline-containing phospholipids ,
The working phospholipid reagent was dispensed iftt l ml li-
quot$ and incubated at 37 °C, for 3 min.,Upon completion of
this preincubation 100 μΐ of the sodium 2-;hydrpxy^3,5-dichloro-
benzenesulfonate reagent was added and mixed. It is possible
to premix the 2-hydroxyrS^-dichlofobenzenesulfon^te and phos-
pholipid reagents, however, the absorbance of the blank may
increase significantly pVer the jperipd of 1-3 d ys. Consequently
we ehose to separate them in order to improve thfe shelf life of
the reagents (i.e., prevent the air catalyzed oxidative eoupling of
the chromogen System). Ten microliters of sample or Standard
were added, mixed and incubated at 37 PC for 12 min. After
incubation the absprbance was measured at 510 nm against a
reagent blank, in which deionized water wa$ substituted f r
sample or Standard. . . ^*
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Determination of cholesterol
Ten rnicroliters of sample or Standard were added and mixed
with l ml of the cholesterol reagent. After a 10 min incubation
at 37 °C, the absorbance was measured at 510 nm against a
reagent blank in which deionized water was substituted for the
sample (14). The values obtained for HOL choline-containing
phospholipids and HDL cholesterol were multiplied by 1.1 to
correct for the dilution of sample due to the addition of the
precipitating reagents.
Results and Discussion
Preliminary experiments were conducted in order to
optimize the activities of the erizymes and the sample
to reagent ratio for the choline-containing phospho-
lipids procedure. Under the described reaction condi-
tions the hydrolysis of the phospholipids, the oxidation
of the choline and the coupling of the indicator reaction
are complete within 10—15 min for the phospholipid
concentrations commonly encountered in the HDL frac-
tion of serum. As described, a 12 min incubation was
used routinely with fresh feageat. However, it was found
to be necessary to extend this incubation to 15 min for
working phospholipid reagent that was 3 days old.
Apart from the necessity of using a slightly longer incuba-
tion in order to reach equilibrium there were no apparent
deleterious effects resülting from the use of 3 day old
working phospholipid reagent. The time required to
reach equilibrium may be checked by plotting a rise
curve, äs described in figure l, using the high Standard
äs a sample. It may be seen in figure l that equilibrium
over the rarige of 1.0—3.0 mmol/1 is reaehed within
15 min.
Phophatidylcholine
immol/ l]
3.0
10
•t [mini
20'
Takayama et al. (8) have demonstrated that under simi-
lar reaction conditions phospholipase D hydrolysis of
the three different phospholipids is complete. We have
previously reported (15) that if not complete that the
degree of hydrolysis of the various phospholipids is
constant and therefore does not present any appreciable
Problems.
The use of calcium äs an activator for phospholipase D
of microbial origin has been described previously (19).
Although it has been reported (l 5) that it was not
necessary to include calcium in the reagent, subsequent
studies indicate that it is a rjecessary ingredient. Figure 2
depicts a plot of calcium concentration versus the rate
of colour development for the assay. It may be seen
that the activity increases markedly up to a calcium
concentration of 0.1 mmol/1 and then remains relatively
constant to 1.0 mmol/1. In order to allow considerable
latitude in reagent preparation, 0.5 mmol/1 calcium was
chosen to be optimal.
0.15
0,10
0.05
0.2 OA 0.6
CaCl2immol/n
0.8 1.0
Fig. 1. Shown are representative rise curves at 37 °C at 510 nm,
for three levels of phosphatidylchoiine, 1. , 2.0 and 3.0
mmol/1.
Fig. 2. Shown are the effects of calcium on the rate.of colour
development, at 510 nm, with the choline-containing
phospholipid assay.
As has been described previously Triton X-100 is in-
chided in the reagent äs a sqlubilizer of reagents and
samples (15) äs well äs an activator of microbial phospho-
lipase D (19).
Unlike the phospholipase D from cabbage which shows
activity primarily towards phosphatidylcholine, the
phospholipase D of microbial origin exhibits activity
towards other phospholipids such äs phosphatidyl-
ethanolamine äs well äs the other choline-containing
phospholipids, lysophqsphatidylcholine and sphingo-
myelin (15,19). However, since choline oxidase is
specific for choline and the intermediate betaine al-
dehyde (20), only the choline-containing phospholipids
are measured in this procedure. Measuring only the
cholirle-containirig phospholipids still gives an accurate
representation of the overall phospholipid level in serum,
äs the choline-containing phospholipids typically com-
prise something greater than 91% of the total serum
phqspholipids (9,10). It is also of note that the choline-
containing phospholipid content of the HDL fraction is
sirnilar to that of whole serum (9).
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The concentration of choline-containing phospholipids
in this report is expressed in units of mmol/1 rather than
mg/dl due to the heterogeneity of the phospholipids.
Phosphatidylcholine, lysophosphatidylcholine and
sphingomyelin differ from each other in their basic
structures äs well äs within their separate classes with
regard to the degree of Saturation and length of their
fatty acid chain(s) (9). It would seem to follow that the
choline-containing phospholipid concentration of serum
should not be readily compared to the concentration of
a homogeneous Standard on a weight per unit volume
basis. By using a synthetic phosphatidylcholine whose
molecular weight is known, it is possible to relate the
absorbance obtained to the number of moles of choline
released, and therefore to the number of moles of
choline-containing phospholipid in the sample.
In a previous report (14), the Substitution of 2-hyd Oxy-
3,5-dichlo obenzenesulfonate for phenol in an enzyma-
tic HOL cholesterol procedure was described. The Sub-
stitution resulted in a 4.4 fold increase in sensitivity äs
well äs an increase in the precision of the procedure.
The enzymatic determination of choline-containing
phospholipids is already iriherently more sensitive than
that of cholesterol, since the choline oxidase catalyzed
oxidation of one mole of choline produces two moles
of hydrogen peroxide while oxidation of one mole of
cholesterol by cholesterol oxidase produces but one
mole of hydrogen peroxide. This can be more easily
seen in a plot of their respective Standard curves (fig. 3).
1
0.6
0.2
0.0 2.0
c[mmol/l]
4.0
Fig. 3. Shown are repräsentative Standard curves, at 510 nm, for
choline (a; m = 0.478) and choiesterol (b; m = 0.262)
utilizing the same indicator reaction.
These curves were obtained with equimplar amounts of
choline and cholesterol, using their respective oxidases
tp generate hydrogen peroxide. Peroxidase was then
used in the oxidative coupling of 4-aminoantipyrine
and 2-hydroxy-3,5-dichlorobenzenesulföriate to form
the measured chromogen. It may be determined from
figure 3 that the slope of the curve for the HOL
choline-containing phospholipids assay is nearly twice
that of the cholesterol assay, on a molar basis. The
increased sensitivity due to the Substitution of 2-hy-
droxy-3,5-dichlorobenzenesulfonate for phenol has
also produced an increase in the precision of the HOL
choline-containing phospholipids assay. The precision
of the HOL choline-containing phospHolipids assay
was checked by assaying several aliquots of varipus
serum pools. Oh the basis of the data preserited in
table l both the within-run and between-irun repro-
ducibility of the proposed procedüre was judged to be
acceptable.
Tab. 1. Reproducibility of the proposed cholinescontäining
phospholipid procedüre.
Within-run
N3 SD
(mmol/1) (mmol/1
20 0.920 0.022
20 1.890 0.024
Betwfeen tun
CV N SD
) (%) (mmpl/1) (mmol/1
2.4 20 0,990 0.046
1.3 20 1.94 Ö.Ö81
cv
:) (%)
4.6
4.2
aWhere: N = number of tests, ^ mean value, SD = Standard
deviation, and CV - cpefficieiit of Variation.
The determination of the choline-containing phospho-
lipids in the HDL fräction of serum following chemical
precipitatiori of the LDL and VLDL fractipns may be
considered to be controversial. Switzer &Eder (21)
have reported that lysplecithin comprises 9.6% ofthe
total phospholipids of serum and that a major portion
of this phospholipid is associated with albumin and
thu's would not be precipitated with the LDL and
VLDL molecules. Hpwever, in a more recent review
(22) no mention of this phenomenon was made but
rather it was stated that all of the lipids, apart frorn
the free fatty acids, were carried in the plasina äs lipo-
protein complexes. As well, recent studies that have
compared chemical fräctionatiori to electrophoresis (1)
and ultracentrifugation (11, 23) have reipörted good
correlation between the techniques and have made np
mention of an albumin-lysplecithin complex. More
recently, Wille (24) reported that there is an albuitiin-
apolippprötein A-I complex in serum which is able to
bind lysolecithin. This complex has an electrpphpretic
mobility similar tp albuinin and appears in the
d > l .21 kg/l (VHDL) fraction obtained by ultra-
centrifugation. Further, this complex is able to bind
more lysolecithin than albumin can alpne. Since this
complex contains apolipoprotein A-I, which appärently
binds most Pf the lysolecithin in the complex,'it seems
reasonable to include the lysolecithin of this complex
in the determination of HDL choline-containing phospho-
lipids. Therefore, on the basis of this leport, the above
mentioned comparative studies (l, 11,23) and the
inherent ease and convenienee of chejmicäl fractionation
we chose to adopt the fnethod. * ?
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The combination of rnagnesium acetate and dextran
sulfate 500 was chosen äs the precipitating agents for
the HOL choline-containing phospholipid assay due to
their previous use in the determination of HOL chol-
esterol (14). It was shown in this previous report that
magnesium/dextran sulfate 500 did not interfere in the
enzymatic determination of HOL cholesterol. In a sub-
sequent paper (16), magnesium/dextran sulfate 500
was compared with magnesium/phosphotungstate,
manganese/heparin and polyethylene glycol 6000 for
possible interference with the determination of chol-
esterol and was found not to interfere. Since the HDL
choline-containing phospholipid assay involves a differ-
ent enzymic sequence under different reaction condi-
tions, it seemed necessary to repeat the interference
study with the magnesium/dextran sulfate reagents.
This was done by comparing the performance of the
normal reagent with that of a reagent contaminated
with magnesium/dextran sulfate 500. The Contaminated
reagent was prepared to contain magnesium/dextran
sulfate 500 to the concentration that would be present
if 10 of an HDL fraction had been added to l .0 ml of
reagent. A series of spectra obtained using the contam-
inated and the uncontaminated reagents with lecithin
Standards are shown in figure 4. Our previous study
(16) indicated that the precipitating agents do not
cause any measurement problems if the reactions are
carried out at 37 °C äs described under procedufe. There
425 600
Xtnm]
Fig. 4. Shown are the comparative spectra for the chöline-
containing phospholipid assay, over the concentration
ränge of 0.5-2.0 mmol/1, in-the presence (a) and absence
(b) of the precipitating reagents rnagnesium acetate and
dextran sulfate 500.
appears to be no consistent difference between the
spectra obtained with the eontamined reagent and the
spectra obtained with the uncontaminated reagent. The
spectra are intended to show the lack of any obvious
interference due to the magnesium/dextran sulfate. The
small difference between contaminated and uncontami-
nated spectra are probably due to the experimental
error, in that repeated studies in which single wave-
length measurements at 510 nm were made failed to
reveal an interference.
There has been a great interest in the determination of
serum HDL cholesterol levels due to its proposed in-
volvement in the atherosclerotic process. The HDL
molecule has been postulated to pick up cholesterol
from peripheral tissues for transfer to other lipoproteins
or for transport to the liver for disposal (25). This
removal of cholesterol is also proposed to involve the
enzyme lecithin: cholesterol acyltransferase which is
activated by apolipoprotein A-I of the HDL molecule.
The esterification of cholesterol by the transfer of a
fatty acid from lecithin is catalyzed by lecithin:
cholesterol^scyltransferase (25). However, it is not yet
known whether or not this proposed role of HDL is the
mechanism for its protective nature. Since at least part
of the role of phospholipids in the serum lipoproteins
is to allow the lipoproteins to cany the neutral lipids,
it would seem to be reasonable that one might expect
to find a correlation between HDL cholesterol and HDL
cholinercontaining phospholipids. For this reason, and
äs a possible application of this method, we obtained
55 serum sämples whose total cholesterol levels ranged
from 82 to 437 mg/dl (2.1-11.3 mmol/1) and deter-
mined their levels of HDL eholesterol and HDL choline-
containing phospholipids. A plot of HDL cholesterol vs
HDL choline-containing phospholipids is shown in
figure 5. There appears to be a linear relationship be-
-
El
0 1 2 3
HDL choline containing phospholipid [mrool/U
Fig. 5. Plotted is the correlation between HDL-cholesterol and
HDL-choline-containing phospholipid concentrations.
N * 55; r = 0.913; y - 1.12 - 0.34.
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tween the two, äs evidenced by the coefficient of cor-
relation of 0.913. As well, it may be noted that there is
a negative intercept suggesting that there may be meas-
urable amounts of phospholipids present when there is
no detectable cholesterol. This preliminary data appears
to correlate well with the work of previous investigators
(3,9,11-13, 23). Although comparison of the HOL
phospholipid concentrations is difficult, due to the use
of units based on a weight per unit volume rather than
a moles per liter System, it would appear that our mean
value of l .368 mmol/1 HOL choline-containing phospho-
lipid falls in the middle of the apparent ränge of mean
values of 0.570-1.834 mmol/1 that we calculated from
previous reports (3,9,11-13,23). In addition, the
good correlation obtained between HOL cholesterol
and choline-containing phospholipids, demonstrated in
flgure 5 (r - 0.913) is consistent with the previous
studies of the investigators on this controversial issue
(11-13, 23). The determination of MDL choline-con-
taining phospholipids may prove to be iuseful in the
investigation of the atherosclerotic process. The described
procedure would appear to be more convenient than the
traditional method (26) and more sensitive and re-
producible than the previous enzymic procedure (8,11).
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